Chronic Refractory Cough Market Size To Hit US$ 13,821.3 Million By 2033
According to IMARC Group’s latest report, titled “Chronic Refractory Cough Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033”, The 7 major chronic refractory cough markets reached a value of US$ 9,054.8 Million in 2022. Looking forward, IMARC Group expects the 7MM to reach US$ 13,821.3 Million by 2033, exhibiting a growth rate (CAGR) of 3.9% during 2023-2033.This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.
Industry Definition and Application:
Chronic refractory cough (CRC) refers to an ailment in which an individual experiences a persistent cough that lasts for more than eight weeks, even after undergoing multiple treatments. The main symptoms of the disease involves a dry, irritated cough localized around the laryngeal area, dyspnea, dysphonia, dizziness, continuous chest pain, night sweats, and physical complications like urinary incontinence, fractured ribs, and muscle strain. The diagnosis of CRC typically requires the identification of a patient's clinical features, medical history, physical examination, blood workup, pulmonary function tests, allergy tests, etc.
Request for a Free Sample Copy of this Report: https://www.imarcgroup.com/chronic-refractory-cough-market/requestsample
What are the growth prospects and trends in the industry?
The growing cases of respiratory tract disorders secondary to sensory nerve damage caused by viral infections and inflammation are primarily augmenting the chronic refractory cough market. Furthermore, the increasing instances of several risk factors, such as smoking, acid reflux, asthma, exposure to irritants, etc., that can irritate the airways, are also contributing to the market growth. Apart from this, the escalating utilization of neuromodulating agents, including gabapentin and amitriptyline, as they act on the heightened neural sensitization that is associated with the pathogenesis of CRC, is providing lucrative growth opportunities to the market.
Moreover, the rising adoption of non-pharmacological interventions, like cough-suppression physiotherapy and speech therapy, in patients who have not responded to conventional medications is creating a positive outlook for the market. Additionally, the emerging popularity of superior laryngeal nerve block as a long-term treatment option on account of its numerous advantages, such as high patient compliance, feasibility, safety, and improved quality of life, is expected to propel the chronic refractory cough market in the coming years.
Countries Covered:
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan
Analysis Covered Across Each Country
- Historical, current, and future epidemiology scenario
- Historical, current, and future performance of the chronic refractory cough market
- Historical, current, and future performance of various therapeutic categories in the market
- Sales of various drugs across the chronic refractory cough market
- Reimbursement scenario in the market
- In-market and pipeline drugs
This report also provides a detailed analysis of the current chronic refractory cough marketed drugs and late-stage pipeline drugs.
In-Market Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
- Drug overview
- Mechanism of action
- Regulatory status
- Clinical trial results
- Drug uptake and market performance
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=7476&flag=C
Competitive Landscape With Key Players:
The competitive landscape of the chronic refractory cough market has been studied in the report with the detailed profiles of the key players operating in the market.
Key Highlights of the Report:
- Market Performance (2017-2022)
- Market Outlook (2023-2033)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com/